US 10463749
Maytansinoid derivatives, conjugates thereof, and methods of use
granted A61KA61K31/537A61K47/68
Quick answer
US patent 10463749 (Maytansinoid derivatives, conjugates thereof, and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/537, A61K47/68, A61K47/6851, A61P